Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

A cell-based high-content screening assay reveals activators and inhibitors of cancer cell invasion.

Quintavalle M, Elia L, Price JH, Heynen-Genel S, Courtneidge SA.

Sci Signal. 2011 Jul 26;4(183):ra49. doi: 10.1126/scisignal.2002032.

2.

Caldesmon suppresses cancer cell invasion by regulating podosome/invadopodium formation.

Yoshio T, Morita T, Kimura Y, Tsujii M, Hayashi N, Sobue K.

FEBS Lett. 2007 Aug 7;581(20):3777-82. Epub 2007 Jul 5.

3.

Molecular mechanisms of invadopodium formation: the role of the N-WASP-Arp2/3 complex pathway and cofilin.

Yamaguchi H, Lorenz M, Kempiak S, Sarmiento C, Coniglio S, Symons M, Segall J, Eddy R, Miki H, Takenawa T, Condeelis J.

J Cell Biol. 2005 Jan 31;168(3):441-52.

4.

Lipid rafts and caveolin-1 are required for invadopodia formation and extracellular matrix degradation by human breast cancer cells.

Yamaguchi H, Takeo Y, Yoshida S, Kouchi Z, Nakamura Y, Fukami K.

Cancer Res. 2009 Nov 15;69(22):8594-602. doi: 10.1158/0008-5472.CAN-09-2305. Epub 2009 Nov 3.

5.

Impact of flavonoids on matrix metalloproteinase secretion and invadopodia formation in highly invasive A431-III cancer cells.

Lin YC, Tsai PH, Lin CY, Cheng CH, Lin TH, Lee KP, Huang KY, Chen SH, Hwang JJ, Kandaswami CC, Lee MT.

PLoS One. 2013 Aug 21;8(8):e71903. doi: 10.1371/journal.pone.0071903. eCollection 2013.

6.

Dynamic membrane remodeling at invadopodia differentiates invadopodia from podosomes.

Artym VV, Matsumoto K, Mueller SC, Yamada KM.

Eur J Cell Biol. 2011 Feb-Mar;90(2-3):172-80. doi: 10.1016/j.ejcb.2010.06.006. Epub 2010 Jul 24.

7.

Small-molecule screening of PC3 prostate cancer cells identifies tilorone dihydrochloride to selectively inhibit cell growth based on cyclin-dependent kinase 5 expression.

Wissing MD, Dadon T, Kim E, Piontek KB, Shim JS, Kaelber NS, Liu JO, Kachhap SK, Nelkin BD.

Oncol Rep. 2014 Jul;32(1):419-24. doi: 10.3892/or.2014.3174. Epub 2014 May 13.

8.

APC/β-catenin-rich complexes at membrane protrusions regulate mammary tumor cell migration and mesenchymal morphology.

Odenwald MA, Prosperi JR, Goss KH.

BMC Cancer. 2013 Jan 9;13:12. doi: 10.1186/1471-2407-13-12.

9.

Cdc42-interacting protein 4 promotes breast cancer cell invasion and formation of invadopodia through activation of N-WASp.

Pichot CS, Arvanitis C, Hartig SM, Jensen SA, Bechill J, Marzouk S, Yu J, Frost JA, Corey SJ.

Cancer Res. 2010 Nov 1;70(21):8347-56. doi: 10.1158/0008-5472.CAN-09-4149. Epub 2010 Oct 12.

10.

TIS21/BTG2 inhibits invadopodia formation by downregulating reactive oxygen species level in MDA-MB-231 cells.

Choi JA, Lim IK.

J Cancer Res Clin Oncol. 2013 Oct;139(10):1657-65. doi: 10.1007/s00432-013-1484-3. Epub 2013 Aug 2.

PMID:
23907596
11.

The role of the exocyst in matrix metalloproteinase secretion and actin dynamics during tumor cell invadopodia formation.

Liu J, Yue P, Artym VV, Mueller SC, Guo W.

Mol Biol Cell. 2009 Aug;20(16):3763-71. doi: 10.1091/mbc.E08-09-0967. Epub 2009 Jun 17.

12.

Multiple regulatory inputs converge on cortactin to control invadopodia biogenesis and extracellular matrix degradation.

Ayala I, Baldassarre M, Giacchetti G, Caldieri G, Tetè S, Luini A, Buccione R.

J Cell Sci. 2008 Feb 1;121(Pt 3):369-78. doi: 10.1242/jcs.008037. Epub 2008 Jan 15.

13.

Functional invadopodia formation through stabilization of the PDPN transcript by IMP-3 and cancer-stromal crosstalk for PDPN expression.

Hwang YS, Xianglan Z, Park KK, Chung WY.

Carcinogenesis. 2012 Nov;33(11):2135-46. doi: 10.1093/carcin/bgs258. Epub 2012 Aug 1.

14.

Regulation of invadopodia formation and activity by CD147.

Grass GD, Bratoeva M, Toole BP.

J Cell Sci. 2012 Feb 1;125(Pt 3):777-88. doi: 10.1242/jcs.097956.

15.

AC1MMYR2 impairs high dose paclitaxel-induced tumor metastasis by targeting miR-21/CDK5 axis.

Ren Y, Zhou X, Yang JJ, Liu X, Zhao XH, Wang QX, Han L, Song X, Zhu ZY, Tian WP, Zhang L, Mei M, Kang CS.

Cancer Lett. 2015 Jul 1;362(2):174-82. doi: 10.1016/j.canlet.2015.03.038. Epub 2015 Mar 28.

PMID:
25827073
16.

Stratifying fascin and cortactin function in invadopodium formation using inhibitory nanobodies and targeted subcellular delocalization.

Van Audenhove I, Boucherie C, Pieters L, Zwaenepoel O, Vanloo B, Martens E, Verbrugge C, Hassanzadeh-Ghassabeh G, Vandekerckhove J, Cornelissen M, De Ganck A, Gettemans J.

FASEB J. 2014 Apr;28(4):1805-18. doi: 10.1096/fj.13-242537. Epub 2014 Jan 10.

17.

SRC regulates actin dynamics and invasion of malignant glial cells in three dimensions.

Angers-Loustau A, Hering R, Werbowetski TE, Kaplan DR, Del Maestro RF.

Mol Cancer Res. 2004 Nov;2(11):595-605.

18.

Phosphatidylinositol 4,5-bisphosphate and PIP5-kinase Ialpha are required for invadopodia formation in human breast cancer cells.

Yamaguchi H, Yoshida S, Muroi E, Kawamura M, Kouchi Z, Nakamura Y, Sakai R, Fukami K.

Cancer Sci. 2010 Jul;101(7):1632-8. doi: 10.1111/j.1349-7006.2010.01574.x. Epub 2010 Mar 24.

19.

N-WASP-mediated invadopodium formation is involved in intravasation and lung metastasis of mammary tumors.

Gligorijevic B, Wyckoff J, Yamaguchi H, Wang Y, Roussos ET, Condeelis J.

J Cell Sci. 2012 Feb 1;125(Pt 3):724-34. doi: 10.1242/jcs.092726.

20.

All-trans retinoic acid induces DU145 cell cycle arrest through Cdk5 activation.

Lin E, Chen MC, Huang CY, Hsu SL, Huang WJ, Lin MS, Wu JC, Lin H.

Cell Physiol Biochem. 2014;33(6):1620-30. doi: 10.1159/000358724. Epub 2014 May 16.

PMID:
24851929
Items per page

Supplemental Content

Write to the Help Desk